Moderna, Inc. (MRNA) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-15 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Moderna, Inc. (MRNA) CIK: 0001682852 --- Reporting Owner --- Name: Hoge Stephen CIK: 0001760669 Role: Officer (President) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-15 | Code: M (Exercise of derivative) Shares: +37,226 | Price: $19.15 Total Value: $712,877.90 Shares Owned After: 1,521,074 | Ownership: D (Direct) Footnotes: [F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. [Transaction #2] Security: Common Stock Date: 2026-07-15 | Code: M (Exercise of derivative) Shares: +16,110 | Price: $19.15 Total Value: $308,506.50 Shares Owned After: 1,537,184 | Ownership: D (Direct) Footnotes: [F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. [Transaction #3] Security: Common Stock Date: 2026-07-15 | Code: S (Open market sale) Shares: -53,336 | Price: $67.60 Total Value: $3,605,513.60 Shares Owned After: 1,483,848 | Ownership: D (Direct) Footnotes: [F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-07-15 | Code: M (Exercise of derivative) Shares: -37,226 | Price: $0.00 Exercisable: N/A | Expires: 2026-08-10 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. [F3] This option is fully vested and exercisable. [Transaction #2] Security: Stock Option (Right to Buy) Date: 2026-07-15 | Code: M (Exercise of derivative) Shares: -16,110 | Price: $0.00 Exercisable: N/A | Expires: 2026-08-10 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. [F3] This option is fully vested and exercisable. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) [Holding #2] Security: Common Stock Ownership: I (Indirect) Footnotes: [F2] These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. --- Footnotes (Complete Index) --- F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2025. F2: These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. F3: This option is fully vested and exercisable. --- Signature --- /s/ /s/ James Dillon, as Attorney-in-Fact (2026-07-16)